| Mrs Sherilyn Kaye Medina, CRNA | |
|
2401 S 31st St, Temple, TX 76508-6533 | |
| (254) 724-2111 | |
| Not Available |
| Full Name | Mrs Sherilyn Kaye Medina |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 2401 S 31st St, Temple, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013178938 | NPI | - | NPPES |
| 323958403 | Medicaid | TX | |
| 323958404 | Other | TX | CSHCN |
| Entity Name | U S Anesthesia Partners Of Texas, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548208564 PECOS PAC ID: 7315850351 Enrollment ID: O20031106000563 |
News Archive
Whether you like to burn the midnight oil to check emails or binge watch your favorite series, toss and turn or sleep until mid-morning, it seems the amount of sleep you get matters when it comes to your future vascular and heart health.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 5 days ago
| Entity Name | Northwest Anesthesiology & Pain Services, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629027511 PECOS PAC ID: 9638067408 Enrollment ID: O20040304001244 |
News Archive
Whether you like to burn the midnight oil to check emails or binge watch your favorite series, toss and turn or sleep until mid-morning, it seems the amount of sleep you get matters when it comes to your future vascular and heart health.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 5 days ago
| Entity Name | Seema A Dar Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942390901 PECOS PAC ID: 7315998937 Enrollment ID: O20050201000635 |
News Archive
Whether you like to burn the midnight oil to check emails or binge watch your favorite series, toss and turn or sleep until mid-morning, it seems the amount of sleep you get matters when it comes to your future vascular and heart health.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 5 days ago
| Entity Name | Texas Institute Of Gastroenterology Associates , Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538267067 PECOS PAC ID: 7012927056 Enrollment ID: O20060504000434 |
News Archive
Whether you like to burn the midnight oil to check emails or binge watch your favorite series, toss and turn or sleep until mid-morning, it seems the amount of sleep you get matters when it comes to your future vascular and heart health.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 5 days ago
| Entity Name | Joycelyn M. Theard M.d,p.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346424231 PECOS PAC ID: 7214015817 Enrollment ID: O20080630000289 |
News Archive
Whether you like to burn the midnight oil to check emails or binge watch your favorite series, toss and turn or sleep until mid-morning, it seems the amount of sleep you get matters when it comes to your future vascular and heart health.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 5 days ago
| Entity Name | Youngs Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922178599 PECOS PAC ID: 2163524992 Enrollment ID: O20120104000614 |
News Archive
Whether you like to burn the midnight oil to check emails or binge watch your favorite series, toss and turn or sleep until mid-morning, it seems the amount of sleep you get matters when it comes to your future vascular and heart health.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 5 days ago
| Entity Name | Best Choice Anesthesia & Pain Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699015628 PECOS PAC ID: 5496994626 Enrollment ID: O20130620000143 |
News Archive
Whether you like to burn the midnight oil to check emails or binge watch your favorite series, toss and turn or sleep until mid-morning, it seems the amount of sleep you get matters when it comes to your future vascular and heart health.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 5 days ago
| Entity Name | Gcsa Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184017741 PECOS PAC ID: 8729392667 Enrollment ID: O20150805007675 |
News Archive
Whether you like to burn the midnight oil to check emails or binge watch your favorite series, toss and turn or sleep until mid-morning, it seems the amount of sleep you get matters when it comes to your future vascular and heart health.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 5 days ago
| Entity Name | Radius Anesthesia Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891157475 PECOS PAC ID: 8123327996 Enrollment ID: O20160428001617 |
News Archive
Whether you like to burn the midnight oil to check emails or binge watch your favorite series, toss and turn or sleep until mid-morning, it seems the amount of sleep you get matters when it comes to your future vascular and heart health.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 5 days ago
| Entity Name | Northstar Anesthesia Ii Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477066405 PECOS PAC ID: 2365701737 Enrollment ID: O20180110000102 |
News Archive
Whether you like to burn the midnight oil to check emails or binge watch your favorite series, toss and turn or sleep until mid-morning, it seems the amount of sleep you get matters when it comes to your future vascular and heart health.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 5 days ago
| Entity Name | Emergenchealth Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467970897 PECOS PAC ID: 1355606641 Enrollment ID: O20180608000439 |
News Archive
Whether you like to burn the midnight oil to check emails or binge watch your favorite series, toss and turn or sleep until mid-morning, it seems the amount of sleep you get matters when it comes to your future vascular and heart health.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 5 days ago
| Entity Name | Ect Anesthesia Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467980706 PECOS PAC ID: 8628493947 Enrollment ID: O20200804001998 |
News Archive
Whether you like to burn the midnight oil to check emails or binge watch your favorite series, toss and turn or sleep until mid-morning, it seems the amount of sleep you get matters when it comes to your future vascular and heart health.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 5 days ago
| Entity Name | Celebrity Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679193197 PECOS PAC ID: 8325467608 Enrollment ID: O20201006002351 |
News Archive
Whether you like to burn the midnight oil to check emails or binge watch your favorite series, toss and turn or sleep until mid-morning, it seems the amount of sleep you get matters when it comes to your future vascular and heart health.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Sherilyn Kaye Medina, CRNA Po Box 844658, Dallas, TX 75284-4658 Ph: () - | Mrs Sherilyn Kaye Medina, CRNA 2401 S 31st St, Temple, TX 76508-6533 Ph: (254) 724-2111 |
News Archive
Whether you like to burn the midnight oil to check emails or binge watch your favorite series, toss and turn or sleep until mid-morning, it seems the amount of sleep you get matters when it comes to your future vascular and heart health.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
The American Society of Hematology has developed specific recommendations to the scientific community and federal agencies to help propel collaborative research in regenerative medicine in order to make real strides in improving patient care. These recommendations were released today in Blood, ASH's premier scientific journal, in the article titled "Enhancing Research in Regenerative Medicine."
According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.
› Verified 5 days ago
Mr. Nicholas Grant Smith, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76504 Phone: 254-724-2111 | |
John Murphy, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Justin Robert Anders, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Joshua Joseph Philippon, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 Fax: 254-724-7603 | |
Clarence E. Grunden, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1905 Sw H K Dodgen Loop, Temple, TX 76502 Phone: 254-298-2682 Fax: 254-778-7197 | |
Maelen Bernasor, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |